AbbVie Total Current Liabilities 2010-2024 | ABBV

AbbVie total current liabilities for the quarter ending September 30, 2024 were $41.915B, a 30.01% increase year-over-year.

  • AbbVie total current liabilities for 2023 were $37.841B, a 28.11% increase from 2022.
  • AbbVie total current liabilities for 2022 were $29.538B, a 16.07% decline from 2021.
  • AbbVie total current liabilities for 2021 were $35.194B, a 22.79% increase from 2020.

AbbVie Total Current Liabilities 2010-2024 | ABBV

  • AbbVie total current liabilities for 2023 were $37.841B, a 28.11% increase from 2022.
  • AbbVie total current liabilities for 2022 were $29.538B, a 16.07% decline from 2021.
  • AbbVie total current liabilities for 2021 were $35.194B, a 22.79% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B